Dose Monitoring Device Market by Type (Active, Passive), Application (Computed Radiography, Fluoroscopy & Interventional Imaging, Mammography) - Global Forecast 2024-2030

Dose Monitoring Device Market by Type (Active, Passive), Application (Computed Radiography, Fluoroscopy & Interventional Imaging, Mammography) - Global Forecast 2024-2030

The Dose Monitoring Device Market size was estimated at USD 3.32 billion in 2023 and expected to reach USD 3.60 billion in 2024, at a CAGR 8.62% to reach USD 5.92 billion by 2030.

A dose monitoring device is an advanced technological tool designed for accurately measuring and tracking the radiation doses a patient receives during diagnostic imaging procedures. The dose monitoring devices play a crucial role in ensuring patient safety by minimizing exposure to unnecessary radiation, thereby adhering to the principle of As Low As Reasonably Achievable (ALARA) in radiographic practices. Dose monitoring devices can be integrated with various imaging equipment, such as CT scanners, X-ray machines, and mammography units, providing real-time data and alerts to healthcare professionals. This enables the optimization of imaging protocols, ensuring that each patient receives the precise amount of radiation required for accurate diagnosis while minimizing health risks. The rising incidences of chronic diseases requiring precision medicine and the increasing adoption of advanced healthcare technologies are driving the growth of the dose-monitoring device market. However, technical complexities associated with integration into existing healthcare IT infrastructures hinder the adoption of dose-monitoring devices. Enhancing interoperability with electronic health records (EHRs) and developing software-as-a-service (SaaS) platforms for data management and analysis offer remunerative opportunities for the growth of the dose monitoring device market.

Regional Insights

In the Americas, especially in the United States and Canada, there has been innovation and adoption of dose monitoring devices due to high healthcare expenditure, technological advancements, and a strong emphasis on patient safety. The need for dose monitoring devices in the U.S. is further bolstered by stringent regulations and patient awareness programs. Canada's dose monitoring device market is driven by national healthcare policies focusing on patient safety and medication accuracy. Government incentives for healthcare providers to adopt digital health technologies are notable. The surge in healthcare investments and a rising awareness of medication safety propel demand for dose monitoring devices in the Asia-Pacific region. China is witnessing an increase in the adoption of dose monitoring devices with considerable investments in healthcare infrastructure and a booming pharmaceutical industry. The need for precision medicine is rising in Japan, driven by an aging population and the increasing prevalence of chronic diseases. This trend underscores the critical need for advanced dose monitoring devices to ensure accurate and individualized treatment regimens. Rapid urbanization and healthcare reform drive demand for dose monitoring devices in India. The EU countries are highlighted by their unified regulations, including the Medical Devices Regulation (MDR), which emphasizes high quality and safety standards for dose monitoring devices. The Middle East region is witnessing growth through strategic investments in healthcare infrastructure and a growing emphasis on chronic disease management. The African dose monitoring device market showcases increasing investments in healthcare infrastructure, laying the groundwork for future growth.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Dose Monitoring Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increasing aging population and rising incidence of chronic diseases globally
Growing investments by healthcare systems and individuals in imaging technologies
Rising use of diagnostic imaging modalities and the increasing awareness regarding radiation safety

Market Restraints

High cost associated with the advanced dose monitoring technologies

Market Opportunities

Ongoing advancements in dose monitoring technologies
Enhancing interoperability of dose monitoring technologies with advanced imaging technologies

Market Challenges

Data privacy and security concerns associated with the use of digital and connected dose monitoring devices

Market Segmentation Analysis

Type: Increasing use of passive dose monitoring devices owing to their accuracy, reusability, and long-term exposure tracking capability
Application: Extensive use of dose monitoring devices in computed radiography (CR) to manage and optimize radiation doses

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dose Monitoring Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dose Monitoring Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Dozee introduces ambulatory connected patient monitoring system Dozee Pro Ex’

Dozee introduced Dozee Pro Ex, an ambulatory-connected patient monitoring system designed in India for global usage, signifying a major leap in continuous healthcare monitoring. This advanced system is empowered with wireless wearable sensors for relentless tracking of vital signs such as ECG rhythm, blood pressure, heart rate, oxygen saturation, respiration rate, and temperature. Notably, it integrates an AI-enhanced early warning system that diligently analyzes vital parameter trends, offering prompt notifications of potential clinical deteriorations. This technology enables healthcare providers to efficiently monitor patients - whether in bed, moving within hospital premises, or at home - through a centralized control center and dedicated mobile applications for medical professionals.

FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease

In a significant advancement for Alzheimer's disease treatment, the U.S. Food and Drug Administration (FDA) has granted accelerated approval for LEQEMBI (lecanemab-irmb) 100 mg/mL injection, as announced by Eisai Co., Ltd. and Biogen Inc. This humanized monoclonal antibody, aimed at both soluble and insoluble amyloid beta formations characteristic of Alzheimer's, has shown promise in reducing the accumulation of amyloid beta plaques in the brain, a core feature of the disease. Indicated for patients with mild cognitive impairment or mild dementia stages of Alzheimer's, LEQEMBI necessitates careful patient selection and monitoring, especially for amyloid-related imaging abnormalities (ARIA).

Tracerco announces launch of next generation personal electronic dosimeter range – Tracerco PED2

Tracerco introduced advancement in personal radiation safety; the PED2 dosimeters embody Tracerco's patented detection technology, propelling its legacy of excellence in active dosimetry. The PED2 series, a refined version of the acclaimed PED range, offers superior radiological safety management, especially in demanding conditions. Simon Lambert, Tracerco's Technology Manager, highlights the product's enhanced usability, management ease, and development in collaboration with seasoned users, ensuring an extraordinary market offering.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dose Monitoring Device Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Dose Monitoring Device Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bracco S.p.A., Canon Inc., Dozee, Fuji Electric Co., Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guerbet, IBA Dosimetry GmbH, Infab Corporation, INFINITT Healthcare Co., Ltd., Koninklijke Philips N.V., LANDAUER, Inc. by Fortive Corporation, Medic Vision, Medsquare, Mirion Technologies, Inc., Novarad Corporation, PACSHealth, LLC, QAELUM NV, RaySafe by Fluke Corporation, Sectra AB, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., and Volpara Health Limited.

Market Segmentation & Coverage

This research report categorizes the Dose Monitoring Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Active
Active Area Dosimeters
Electronic Personal Dosimeters (EPDs)
Passive
Film Badges
Optically Stimulated Luminescence Dosimeters (OLDs)
Pocket lonization Chambers
Thermoluminescent Dosimeters (TLDs)
Application
Computed Radiography
Fluoroscopy & Interventional Imaging
Mammography
Radiography
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year